These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 3260854)

  • 1. Emergence of resistance during beta-lactam therapy of gram-negative infections. Bacterial mechanisms and medical responses.
    Pechère JC
    Drugs; 1988; 35 Suppl 2():22-8. PubMed ID: 3260854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergence of resistance in gram-negative bacteria: a risk of broad-spectrum beta-lactam use.
    Dworzack DL
    Drug Intell Clin Pharm; 1986; 20(7-8):562-7. PubMed ID: 3488894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. State of penicillin-binding proteins and requirements for their bactericidal interaction with beta-lactam antibiotics in Serratia marcescens highly resistant to extended-spectrum beta-lactams.
    Gunkel AG; Hechler U; Martin HH
    J Gen Microbiol; 1991 Feb; 137(2):243-52. PubMed ID: 2016583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can penicillins and other beta-lactam antibiotics be used to treat tuberculosis?
    Chambers HF; Moreau D; Yajko D; Miick C; Wagner C; Hackbarth C; Kocagöz S; Rosenberg E; Hadley WK; Nikaido H
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2620-4. PubMed ID: 8592990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Penicillin-binding proteins and beta-lactamases: their effects on the use of cephalosporins and other new beta-lactams.
    Neu HC
    Curr Clin Top Infect Dis; 1987; 8():37-61. PubMed ID: 3077281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms by which imipenem may overcome resistance in gram-negative bacilli.
    Williams RJ; Yang YJ; Livermore DM
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():9-13. PubMed ID: 3493237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mechanisms of resistance to beta-lactam antibiotics].
    Heesemann J
    Infection; 1993; 21 Suppl 1():S4-9. PubMed ID: 8314292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anaerobic bacteria and beta-lactam antibiotics.
    Nord CE; Olsson-Liljequist B
    Scand J Infect Dis Suppl; 1984; 42():72-82. PubMed ID: 6335601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance to beta-lactam antibiotics in anaerobic bacteria.
    Nord CE; Hedberg M
    Rev Infect Dis; 1990; 12 Suppl 2():S231-4. PubMed ID: 2406875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of resistance to beta-lactam antibiotics in Pseudomonas aeruginosa during treatment with new beta-lactams.
    Lerner SA; Quinn JP
    Chemioterapia; 1985 Feb; 4(1):95-101. PubMed ID: 3921267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of resistance to beta-lactam antibiotics in Acinetobacter calcoaceticus.
    Obara M; Nakae T
    J Antimicrob Chemother; 1991 Dec; 28(6):791-800. PubMed ID: 1816177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-lactam resistant Pseudomonas aeruginosa strains emerging during therapy: synergistic resistance mechanisms.
    Pagani L; Debiaggi M; Tenni R; Cereda PM; Landini P; Romero E
    Microbiologica; 1988 Jan; 11(1):47-53. PubMed ID: 2832709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mechanism of susceptibility and resistance of bacteria to beta-lactam antibiotics].
    Tsuji A
    Nihon Rinsho; 1991 Oct; 49(10):2254-60. PubMed ID: 1749080
    [No Abstract]   [Full Text] [Related]  

  • 14. Mechanisms and clinical significance of resistance to new beta-lactam antibiotics.
    Livermore DM; Wood MJ
    Br J Hosp Med; 1990 Oct; 44(4):252-8, 261-3. PubMed ID: 2249100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance to beta-lactams in gram-negative bacteria: relative contributions of beta-lactamase and permeability limitations.
    Nayler JH
    J Antimicrob Chemother; 1987 Jun; 19(6):713-32. PubMed ID: 3301784
    [No Abstract]   [Full Text] [Related]  

  • 16. Mechanisms of beta-lactam resistance in Haemophilus influenzae.
    Gutmann L; Williamson R; Collatz E; Acar JF
    Eur J Clin Microbiol Infect Dis; 1988 Oct; 7(5):610-5. PubMed ID: 3143572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of permeability barriers in resistance to beta-lactam antibiotics.
    Nikaido H
    Pharmacol Ther; 1985; 27(2):197-231. PubMed ID: 2412244
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanisms of resistance of enterococci to beta-lactam antibiotics.
    Fontana R; Canepari P; Lleò MM; Satta G
    Eur J Clin Microbiol Infect Dis; 1990 Feb; 9(2):103-5. PubMed ID: 2180705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural and mechanistic aspects of evolution of beta-lactamases and penicillin-binding proteins.
    Massova I; Mobashery S
    Curr Pharm Des; 1999 Nov; 5(11):929-37. PubMed ID: 10539997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Penicillin--binding protein: the target for beta-lactam antibiotics, beta-lactamases and their inhibitors].
    Lessel J
    Pharm Unserer Zeit; 1996 Jan; 25(1):17-27. PubMed ID: 8882750
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.